.Within this week's episode of "The Best Line," we are actually diving in to Tough Biotech's yearly ...
.The confetti is still flying coming from Eli Lilly's event celebrating the approval of Alzheimer's ...
.Accept to this week's Chutes & Ladders, our summary of significant management hirings, firings a...
.Complying with an inadequate presenting for Lykos Therapeutics' MDMA prospect for trauma at a recen...
.AN2 Rehabs is reassessing its business in feedback to uninspired midphase records, vowing to lay of...
.Merck & Co. is actually spending $700 thousand upfront to challenge Amgen in a blood cancer cell...
.With Gilead Sciences almost an FDA decision for its own liver illness drug seladelpar, the firm has...
.CEO David Ricks can easily see the business setting up tents at basecamp responsible for Eli Lilly ...
.Bed Liquidators has transformed Entero Therapeutics white as a slab. The creditor ordered Entero to...
.Exelixis is surrendering on its tissue factor (TF)- targeting antibody-drug conjugate after wrappin...